文献速递慢阻肺哮喘

靶向人βc受体抑制急性香烟烟雾暴露所致炎症髓系细胞与肺损伤

Targeting the human βc receptor inhibits inflammatory myeloid cells and lung injury caused by acute cigarette smoke exposure.
PubMed 文献 · Respirology · 2022-05-22

本研究使用表达人βc受体的人源化转基因小鼠,在急性香烟烟雾暴露模型中观察到血髓系细胞扩增及肺内单核来源巨噬细胞、中性粒细胞和嗜酸性粒细胞浸润,并伴肺组织损伤与水肿。抑制人βc信号可显著减少上述炎症细胞及MMP-12、IL-17A表达,减轻肺损伤和水肿,提示CSL311是具有治疗潜力的抗体。

要点

  • 急性香烟烟雾暴露通过βc受体信号扩增血髓系细胞并招募炎症细胞入肺。
  • CSL311抑制人βc信号可减少肺内CD11b+巨噬细胞、中性粒细胞和嗜酸性粒细胞。
  • CSL311减轻肺组织损伤和水肿,并降低MMP-12与IL-17A表达。

核心结论

  • CSL311是一种能有效抑制急性香烟烟雾暴露所致免疫病理和肺损伤的治疗性抗体。

研究设计与样本

  • 使用表达人βc受体替代小鼠βc和βIL3的人βc受体转基因小鼠,在急性香烟烟雾暴露模型中评估肺组织损伤。
  • 通过组织学及支气管肺泡灌洗液中白蛋白和乳酸脱氢酶水平评估肺损伤。
  • 转基因小鼠接受抑制人βc信号的抗体CSL311治疗。

主要发现

  • hβc转基因小鼠急性香烟烟雾暴露后血髓系细胞数扩增,肺内招募CD11b+间质型和渗出型巨噬细胞、中性粒细胞和嗜酸性粒细胞。
  • 上述炎症反应伴随肺组织损伤和水肿。
  • CSL311治疗显著减少血和支气管肺泡灌洗液中的髓系细胞数。
  • CSL311显著减少肺CD11b+间质型和渗出型巨噬细胞、中性粒细胞和嗜酸性粒细胞,并伴随MMP-12和IL-17A表达、组织损伤和水肿的显著降低。

临床怎么用

  • 靶向人βc受体信号可能成为减轻香烟烟雾所致肺部炎症和损伤的潜在治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is a devastating disease commonly caused by cigarette smoke (CS) exposure that drives tissue injury by persistently recruiting myeloid cells into the lungs. A significant portion of COPD patients also present with overlapping asthma pathology including eosinophilic inflammation. The βc cytokine family includes granulocyte monocyte-colony-stimulating factor, IL-5 and IL-3 that signal through their common receptor subunit βc to promote the expansion and survival of multiple myeloid cells including monocytes/macrophages, neutrophils and eosinophils. METHODS: We have used our unique human βc receptor transgenic (hβc Tg) mouse strain that expresses human βc instead of mouse βc and βIL3 in an acute CS exposure model. Lung tissue injury was assessed by histology and measurement of albumin and lactate dehydrogenase levels in the bronchoalveolar lavage (BAL) fluid. Transgenic mice were treated with an antibody (CSL311) that inhibits human βc signalling. RESULTS: hβc Tg mice responded to acute CS exposure by expanding blood myeloid cell numbers and recruiting monocyte-derived macrophages (cluster of differentiation 11b+ [CD11b+ ] interstitial and exudative macrophages [IM and ExM]), neutrophils and eosinophils into the lungs. This inflammatory response was associated with lung tissue injury and oedema. Importantly, CSL311 treatment in CS-exposed mice markedly reduced myeloid cell numbers in the blood and BAL compartment. Furthermore, CSL311 significantly reduced lung CD11b+ IM and ExM, neutrophils and eosinophils, and this decline was associated with a significant reduction in matrix metalloproteinase-12 (MMP-12) and IL-17A expression, tissue injury and oedema. CONCLUSION: This study identifies CSL311 as a therapeutic antibody that potently inhibits immunopathology and lung injury caused by acute CS exposure.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Fung NH, Wang H, Vlahos R, et al. Targeting the human βc receptor inhibits inflammatory myeloid cells and lung injury caused by acute cigarette smoke exposure. Respirology. 2022. PMID: 35599245. doi:10.1111/resp.14297

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。